Annual CFF
$1.16 M
-$3.33 M-74.25%
01 December 2023
Summary:
Dogwood Therapeutics annual cash flow from financing activities is currently $1.16 million, with the most recent change of -$3.33 million (-74.25%) on 01 December 2023. During the last 3 years, it has risen by +$1.25 million (+1284.84%).DWTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$70.20 K
-$1.52 M-104.83%
01 September 2024
Summary:
Dogwood Therapeutics quarterly cash flow from financing activities is currently -$70.20 thousand, with the most recent change of -$1.52 million (-104.83%) on 01 September 2024. Over the past year, it has dropped by -$70.20 thousand (-100.00%).DWTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$1.38 M
-$1.23 M-47.02%
01 September 2024
Summary:
Dogwood Therapeutics TTM cash flow from financing activities is currently $1.38 million, with the most recent change of -$1.23 million (-47.02%) on 01 September 2024. Over the past year, it has increased by +$225.80 thousand (+19.53%).DWTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DWTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -100.0% | +19.5% |
| 3 y3 years | +1284.8% | -100.0% | +1516.2% |
| 5 y5 years | -51.2% | - | - |
DWTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -96.5% | -100.2% | -95.9% |
Dogwood Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$70.20 K(-104.8%) | $1.38 M(-47.0%) |
| June 2024 | - | $1.45 M(>+9900.0%) | $2.61 M(+125.6%) |
| Dec 2023 | $1.16 M(-74.2%) | $0.00(-100.0%) | $1.16 M(+8.0%) |
| Sept 2023 | - | $1.16 M(>+9900.0%) | $1.07 M(-76.2%) |
| June 2023 | - | $0.00(-100.0%) | $4.49 M(0.0%) |
| Dec 2022 | $4.49 M(-4701.0%) | -$86.00 K(-101.9%) | $4.49 M(-1.9%) |
| Sept 2022 | - | $4.58 M(>+9900.0%) | $4.58 M(>+9900.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$97.60 K(-100.3%) | $0.00(0.0%) | -$97.60 K(-100.3%) |
| Sept 2021 | - | $0.00(0.0%) | $31.48 M(-0.0%) |
| June 2021 | - | $0.00(-100.0%) | $31.49 M(-2.0%) |
| Mar 2021 | - | -$97.60 K(-100.3%) | $32.12 M(-3.8%) |
| Dec 2020 | $33.38 M(+1307.6%) | $31.58 M(>+9900.0%) | $33.38 M(+1756.0%) |
| Sept 2020 | - | $9500.00(-98.5%) | $1.80 M(+0.5%) |
| June 2020 | - | $626.60 K(-46.1%) | $1.79 M(+53.9%) |
| Mar 2020 | - | $1.16 M | $1.16 M |
| Dec 2019 | $2.37 M(+106.1%) | - | - |
| Dec 2018 | $1.15 M | - | - |
FAQ
- What is Dogwood Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Dogwood Therapeutics?
- What is Dogwood Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dogwood Therapeutics?
- What is Dogwood Therapeutics quarterly CFF year-on-year change?
- What is Dogwood Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dogwood Therapeutics?
- What is Dogwood Therapeutics TTM CFF year-on-year change?
What is Dogwood Therapeutics annual cash flow from financing activities?
The current annual CFF of DWTX is $1.16 M
What is the all time high annual CFF for Dogwood Therapeutics?
Dogwood Therapeutics all-time high annual cash flow from financing activities is $33.38 M
What is Dogwood Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DWTX is -$70.20 K
What is the all time high quarterly CFF for Dogwood Therapeutics?
Dogwood Therapeutics all-time high quarterly cash flow from financing activities is $31.58 M
What is Dogwood Therapeutics quarterly CFF year-on-year change?
Over the past year, DWTX quarterly cash flow from financing activities has changed by -$70.20 K (-100.00%)
What is Dogwood Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DWTX is $1.38 M
What is the all time high TTM CFF for Dogwood Therapeutics?
Dogwood Therapeutics all-time high TTM cash flow from financing activities is $33.38 M
What is Dogwood Therapeutics TTM CFF year-on-year change?
Over the past year, DWTX TTM cash flow from financing activities has changed by +$225.80 K (+19.53%)